-Wendell G Yarbrough Researcher Activity Profile

Research Author Detailed Information 

Wendell G Yarbrough Publication Rate By Year

Wendell G Yarbrough has published 1 paper(s) in 2000, 5 paper(s) in 2006, 3 paper(s) in 2007, 1 paper(s) in 2008, for a total of 10 research publications in total.

Wendell G Wg Yarbrough Author Information

LAST NAME: yarbrough

FIRST NAME: Wendell G

INITIALS: wg

AFFILIATION:

Papers

Wendell G Yarbrough's Publication Record

1. Cortactin is an essential regulator of matrix metalloproteinase secretion and extracellular matrix degradation in invadopodia. Year Published: 2007
Department of Pathology, Vanderbilt University, Nashville, Tennessee 37232, USA.
2. Proteomics: clinical applications for head and neck squamous cell carcinoma. Year Published: 2006
Department of Otolaryngology, Vanderbilt University School of Medicine, Nashville, Tennessee, USA. Wendell.yarbrough@vanderbilt.edu
3. Gene expression profiles identify epithelial-to-mesenchymal transition and activation of nuclear factor-kappaB signaling as characteristics of a high-risk head and neck squamous cell carcinoma. Year Published: 2006
Division of Hematology/Oncology, Department of Medicine, Vanderbilt-Ingram Comprehensive Cancer Center, Vanderbilt University School of Medicine, Nashville, TN 37232-6307, USA. Christine.Chung@vanderbilt.edu
4. Increased expression of nuclear factor E2 p45-related factor 2 (NRF2) in head and neck squamous cell carcinomas. Year Published: 2006
Department of Radiation Oncology, Vanderbilt University School of Medicine, Vanderbilt-Ingram Cancer Center, Nashville, Tennessee 37232, USA.
5. Mutagenic effect of cadmium on tetranucleotide repeats in human cells. Year Published: 2006
Department of Cancer Biology, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN 37232, USA. r.slebos@vanderbilt.edu
6. LZAP, a putative tumor suppressor, selectively inhibits NF-kappaB. Year Published: 2007
Department of Cancer Biology, Vanderbilt University, Nashville, TN 37232, USA.
7. Phosphoinositide kinase-3 status associated with presence or absence of human papillomavirus in head and neck squamous cell carcinomas. Year Published: 2007
Department of Otolaryngology, Vanderbilt University, Nashville, TN 37232-8605, USA. Wendell.yarbrough@vanderbilt.edu
8. Nodal volume reduction after concurrent chemo- and radiotherapy: correlation between initial CT and histopathologic findings. Year Published: 2000
Department of Surgery, University of North Carolina at Chapel Hill, 27599, USA.
9. Proteomics: clinical applications for head and neck squamous cell carcinoma. Year Published: 2006
Department of Otolaryngology, Vanderbilt University School of Medicine, Nashville, Tennessee, USA. Wendell.yarbrough@vanderbilt.edu
10. Microsatellite mutations in buccal cells are associated with aging and head and neck carcinoma. Year Published: 2008
Department of Cancer Biology, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN 37232, USA. r.slebos@vanderbilt.edu